75 related articles for article (PubMed ID: 6138984)
21. In vivo inhibition by intact mouse serum of the activity of the flavivirus-induced T-suppressors of autoreactive T-lymphocytes.
Khozinsky VV; Semenov BF
Acta Virol; 1984 May; 28(3):212-7. PubMed ID: 6147997
[TBL] [Abstract][Full Text] [Related]
22. Poly(D,L-lactic-co-glycolic acid) microsphere delivery of adenovirus for vaccination.
Wang D; Molavi O; Lutsiak ME; Elamanchili P; Kwon GS; Samuel J
J Pharm Pharm Sci; 2007; 10(2):217-30. PubMed ID: 17706180
[TBL] [Abstract][Full Text] [Related]
23. Ixodes scapularis: effects of repeated infestations with pathogen-free nymphs on macrophage and T lymphocyte cytokine responses of BALB/c and C3H/HeN mice.
Schoeler GB; Manweiler SA; Wikel SK
Exp Parasitol; 1999 Aug; 92(4):239-48. PubMed ID: 10425152
[TBL] [Abstract][Full Text] [Related]
24. Murine transfer factor. III. Specific interactions between transfer factor and antigen.
Kirkpatrick CH; Rozzo SJ; Mascali JJ
J Immunol; 1985 Dec; 135(6):4027-33. PubMed ID: 2415595
[TBL] [Abstract][Full Text] [Related]
25. Potential use of attenuated langat E5 virus as a live vaccine -- long term protection against Russian spring-summer encephalitis virus in mice.
Thind S
J Hyg Epidemiol Microbiol Immunol; 1981; 25(2):155-62. PubMed ID: 6265549
[TBL] [Abstract][Full Text] [Related]
26. Infectious cDNA clones of Langat tick-borne flavivirus that differ from their parent in peripheral neurovirulence.
Campbell MS; Pletnev AG
Virology; 2000 Mar; 269(1):225-37. PubMed ID: 10725214
[TBL] [Abstract][Full Text] [Related]
27. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
Green WR
J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
[TBL] [Abstract][Full Text] [Related]
28. Immunization with recombinant vaccinia viruses expressing structural and part of the nonstructural region of tick-borne encephalitis virus cDNA protect mice against lethal encephalitis.
Dmitriev IP; Khromykh AA; Ignatyev GM; Gainullina MN; Ageenko VA; Dryga SA; Vorobyeva MS; Sandakhchiev LS
J Biotechnol; 1996 Jan; 44(1-3):97-103. PubMed ID: 8717392
[TBL] [Abstract][Full Text] [Related]
29. Recognition of herpes simplex virus antigens on the surface of mouse cells of the H-2b haplotype by virus-specific cytotoxic T lymphocytes.
Jennings SR; Rice PL; Pan S; Knowles BB; Tevethia SS
J Immunol; 1984 Jan; 132(1):475-81. PubMed ID: 6197457
[TBL] [Abstract][Full Text] [Related]
30. Highly specific detection of antibodies to tick-borne encephalitis (TBE) virus in humans using a domain III antigen and a sensitive immune complex (IC) ELISA.
Ludolfs D; Reinholz M; Schmitz H
J Clin Virol; 2009 Jun; 45(2):125-8. PubMed ID: 19409841
[TBL] [Abstract][Full Text] [Related]
31. Importance of localized skin infection in tick-borne encephalitis virus transmission.
Labuda M; Austyn JM; Zuffova E; Kozuch O; Fuchsberger N; Lysy J; Nuttall PA
Virology; 1996 May; 219(2):357-66. PubMed ID: 8638401
[TBL] [Abstract][Full Text] [Related]
32. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
[TBL] [Abstract][Full Text] [Related]
33. Characterization of human dialyzable transfer factor from normal and chronic lymphoid leukemia sources.
Goust JM; Marescot MR; Lesourd B; Doumercq S; Moulias R
Biomedicine; 1976 Jan; 24(1):39-44. PubMed ID: 817750
[TBL] [Abstract][Full Text] [Related]
34. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
Sensi M; Orosz CG; Bach FH
J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
[TBL] [Abstract][Full Text] [Related]
35. Relative immunogenicity of hepatitis B virus-encoded antigens as targets for cytotoxic T-cell response.
Ishikawa T; Kakumu S; Yoshioka K; Yamada M; Tanaka K; Higashi Y; Takayanagi M; Okumura A; Kojima A; Tamura T
Immunology; 1993 Oct; 80(2):313-8. PubMed ID: 8262560
[TBL] [Abstract][Full Text] [Related]
36. Antigenic similarity of central European encephalitis and louping-ill viruses.
Hubálek Z; Pow I; Reid HW; Hussain MH
Acta Virol; 1995 Dec; 39(5-6):251-6. PubMed ID: 8722293
[TBL] [Abstract][Full Text] [Related]
37. Isolation from Trypanosoma cruzi-infected mice of CD8+, MHC-restricted cytotoxic T cells that lyse parasite-infected target cells.
Nickell SP; Stryker GA; Arevalo C
J Immunol; 1993 Feb; 150(4):1446-57. PubMed ID: 8432987
[TBL] [Abstract][Full Text] [Related]
38. An abortive form of tick-borne encephalitis (TBE)--a rare clinical manifestation of infection with TBE virus.
Lotric-Furlan S; Avsic-Zupanc T; Strle F
Wien Klin Wochenschr; 2002 Jul; 114(13-14):627-9. PubMed ID: 12422615
[TBL] [Abstract][Full Text] [Related]
39. Characterization of tick-borne encephalitis virus from Latvia.
Mavtchoutko V; Vene S; Haglund M; Forsgren M; Duks A; Kalnina V; Hörling J; Lundkvist A
J Med Virol; 2000 Feb; 60(2):216-22. PubMed ID: 10596024
[TBL] [Abstract][Full Text] [Related]
40. A synthetic peptide based on the NS1 non-structural protein of tick-borne encephalitis virus induces a protective immune response against fatal encephalitis in an experimental animal model.
Volpina OM; Volkova TD; Koroev DO; Ivanov VT; Ozherelkov SV; Khoretonenko MV; Vorovitch MF; Stephenson JR; Timofeev AV
Virus Res; 2005 Sep; 112(1-2):95-9. PubMed ID: 16022903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
